Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spine Asia CoROCO:6758 +3.50%80 EV-to-EBITDA is 18.83 as of Sep. 15, 2026, which is 9% above its 10-year median of 17.22. GuruFocus rates ROCO:6758 with a GF Score™ of 80/100 and a GF Value™ of NT$44.74 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Spine Asia Co ranks worse than 63.37% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Spine Asia Co's enterprise value is NT$516.7 Mil.
Spine Asia Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$27.4 Mil. Therefore, Spine Asia Co's EV-to-EBITDA for today is 18.83.
The historical rank and industry rank for Spine Asia Co's EV-to-EBITDA or its related term are showing as below:
ROCO:6758'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.21 Med: 17.22 Max: 25.3
Current: 18.83
During the past 10 years, the highest EV-to-EBITDA of Spine Asia Co was 25.30. The lowest was 10.21. And the median was 17.22.
ROCO:6758's EV-to-EBITDA is ranked worse than 63.37% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 13.68
vs ROCO:6758: 18.83
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Spine Asia Co (ROCO:6758) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Spine Asia Co's PE Ratio (TTM) for today is calculated as:
Spine Asia Co's share price for today is NT$31.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spine Asia Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.707.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Spine Asia Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6758 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Spine Asia Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spine Asia Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spine Asia Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Spine Asia Co's EV-to-EBITDA falls into.
Spine Asia Co's current Enterprise Value is NT$516.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spine Asia Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$27.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spine Asia Co (ROCO:6758) has a EV-to-EBITDA of 18.83 as of Sep. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Spine Asia Co. This is near median its historical median of 17.22. Over the past decade, Spine Asia Co's EV-to-EBITDA has ranged from 10.21 to 25.30. According to the industry distribution chart, Spine Asia Co ranks #327 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 63.4%.
Is Spine Asia Co's EV-to-EBITDA too high?
Spine Asia Co's current EV-to-EBITDA of 18.83 is near median its 10-year median of 17.22. Over the past 10 years, this metric has ranged from a low of 10.21 to a high of 25.30. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.68. Spine Asia Co's value of 18.83 is 37.6% above this industry median. Based on the distribution chart, Spine Asia Co ranks #327 out of 516 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Spine Asia Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spine Asia Co's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spine Asia Co ranks #327 out of 516 companies for EV-to-EBITDA. This places Spine Asia Co in the lower half of its industry. The industry median EV-to-EBITDA is 13.68. Spine Asia Co's value of 18.83 is 37.6% above this benchmark. Historically, Spine Asia Co's own EV-to-EBITDA has ranged from 10.21 to 25.30 over the past decade. While the company's 10-year median is 17.22 vs. the industry median of 13.68, Spine Asia Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.68, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spine Asia Co's current EV-to-EBITDA of 18.83 is 37.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Spine Asia Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spine Asia Co's current EV-to-EBITDA is 18.83, which is near median its own 10-year median of 17.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spine Asia Co stock overvalued right now?
Based on GuruFocus' analysis, Spine Asia Co (ROCO:6758) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$44.74, compared to a current price of NT$31.05 — trading 30.6% below its estimated fair value. The current EV-to-EBITDA is 18.83, which is near median its 10-year median of 17.22 and 37.6% above the Medical Devices & Instruments industry median of 13.68. Spine Asia Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Spine Asia Co (ROCO:6758), the current EV-to-EBITDA is 18.83 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spine Asia Co (ROCO:6758) Overvalued in 2026?
Based on GuruFocus' analysis, Spine Asia Co stock appears to be undervalued.
The current stock price of NT$31.05 is trading 30.6% below its estimated GF Value™ of NT$44.74.
GuruFocus considers Spine Asia Co to be Significantly Undervalued.
Key valuation signals for ROCO:6758:
EV-to-EBITDA: 18.83 (near median its 10-year median of 17.22)
GF Value™: NT$44.74 vs. price of NT$31.05 (30.6% below fair value)
Industry Position: 37.6% above the Medical Devices & Instruments median (#327 of 516)
No single metric tells the full story. See the ROCO:6758 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spine Asia Co Ltd is a medical device company. It is engaged in the research, development, manufacturing, and marketing of spinal, implants and instruments. The company offers products such as vigor lumbar peek cage, remond polymer cervical cage, and combo cervical disc cage.
80GF Score
Get the complete analysis for ROCO:6758
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6758 has been successfully added to your 
